Dolby Laboratories (DLB) - Total Liabilities
Based on the latest financial reports, Dolby Laboratories (DLB) has total liabilities worth $591.27 Million USD as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Dolby Laboratories (DLB) long-term investment share to see how much of total assets are deployed in long-term investments.
Dolby Laboratories - Total Liabilities Trend (2003–2024)
This chart illustrates how Dolby Laboratories's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see how large is Dolby Laboratories's balance sheet.
Dolby Laboratories Competitors by Total Liabilities
The table below lists competitors of Dolby Laboratories ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Shenzhen Everbest Machinery Indus
SHE:002980
|
China | CN¥981.23 Million |
|
First Advantage Corp
NASDAQ:FA
|
USA | $2.45 Billion |
|
Abcellera Biologics Inc
NASDAQ:ABCL
|
USA | $411.56 Million |
|
Thor Industries Inc
NYSE:THO
|
USA | $2.84 Billion |
|
Ventia Services Group Ltd
AU:VNT
|
Australia | AU$2.34 Billion |
|
GEK TERNA Holdings Real Estate Construction S.A
AT:GEKTERNA
|
Greece | €6.42 Billion |
|
HARBOUR ENE.SP.ADR LS-50
F:PQQ2
|
Germany | €25.54 Billion |
|
Zhuzhou Hongda Electronics Corp Ltd Class A
SHE:300726
|
China | CN¥528.27 Million |
Liability Composition Analysis (2003–2024)
This chart breaks down Dolby Laboratories's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Dolby Laboratories balance sheet independence to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.44 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 1.80 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.23 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.19 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Dolby Laboratories's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Dolby Laboratories (2003–2024)
The table below shows the annual total liabilities of Dolby Laboratories from 2003 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-09-30 | $623.03 Million | +2.54% |
| 2023-09-30 | $607.58 Million | +38.55% |
| 2022-09-30 | $438.53 Million | -12.55% |
| 2021-09-30 | $501.45 Million | +4.71% |
| 2020-09-30 | $478.92 Million | -5.86% |
| 2019-09-30 | $508.72 Million | +9.84% |
| 2018-09-30 | $463.15 Million | +18.84% |
| 2017-09-30 | $389.71 Million | +17.61% |
| 2016-09-30 | $331.37 Million | +3.77% |
| 2015-09-30 | $319.34 Million | +26.54% |
| 2014-09-30 | $252.36 Million | +6.07% |
| 2013-09-30 | $237.92 Million | +9.36% |
| 2012-09-30 | $217.56 Million | +9.31% |
| 2011-09-30 | $199.04 Million | -8.32% |
| 2010-09-30 | $217.09 Million | -0.51% |
| 2009-09-30 | $218.21 Million | -17.59% |
| 2008-09-30 | $264.80 Million | +53.72% |
| 2007-09-30 | $172.26 Million | +37.71% |
| 2006-09-30 | $125.09 Million | +17.04% |
| 2005-09-30 | $106.87 Million | +5.46% |
| 2004-09-30 | $101.34 Million | +9.20% |
| 2003-09-30 | $92.80 Million | -- |
About Dolby Laboratories
Dolby Laboratories, Inc. engages in the design and manufacture of audio, imaging, accessibility, and other hardware and software solutions primarily for application in the television, broadcast, and live entertainment industries in the United States and internationally. The company develops and licenses its audio technologies, such as AAC, HE-AAC, and extended HE-AAC, a digital audio codec soluti… Read more